Table 3.
Multiple logistic regression analyses showing that high risk for significant OSA based on the mNOSAS score was selected by the model with a 14 times risk of developing a severe COVID-19 AE (A), and that the age at admission, the mNOSAS score, reduced dyspnea sensation at admission and the severity of COVID-19 AE were associated with the risk of developing severe disability at discharge (mRS score ≥ 3)
A | ||||
Severe COVID-19 AE | Odds ratio | p value | [95% Confident Interval] | |
Modified NOSAS score | 14.52 | < 0.001 | 4.37 | 48.22 |
B | ||||
mRS | Odds ratio | p value | [95% Confident Interval] | |
Age at admission | 1.07 | 0.018 | 1.01 | 1.13 |
Modified NOSAS score | 1.17 | 0.058 | 0.99 | 1.38 |
Reduced dyspnea at admission | 0.28 | 0.017 | 0.10 | 0.79 |
Severe COVID-19 AE | 7.37 | 0.004 | 1.87 | 29.02 |
Abbreviations: COVID-19 AE COVID-19 acute encephalopathy, OSA Obstructive sleep apnea, mRS modified Rankin Scale